In the subgroup of AFP‐negative HCC patients without cirrhosis after liver resection, the TPS model continued to demonstrate its efficacy in effectively stratifying OS (p < 0.001) and early recurrence (p < 0.001, Figure S3). The gene discussed is AFP; the disease is hepatocellular carcinoma.